On September 7, 2026, Shenguan Biology Science & Technology Investment Company Limited bought 2.51 million shares of SHENGUAN HLDGS (00829) stock at an average of HKD 0.1662 per share, involving about HKD 416,497.
Prior to the acquisition, the declarant's long position in SHENGUAN HLDGS was 1.65 billion shares, representing 50.95%; following the acquisition, the holding changed to 1.65 billion shares, with the long position ratio rising to 51.03%.